Efficacy News and Research

RSS
neuMirRx issued U.S. patent for "methods for enhancing solubility of compounds

neuMirRx issued U.S. patent for "methods for enhancing solubility of compounds

People with severe obstructive sleep apnea often have poor diets

People with severe obstructive sleep apnea often have poor diets

Addex Parkinson's product progressing in early clinical trials

Addex Parkinson's product progressing in early clinical trials

Tribendimidine shows promise for intestinal worm infections

Tribendimidine shows promise for intestinal worm infections

Antiretroviral drug efavirenz associated with better outcomes in HIV-infected adults

Antiretroviral drug efavirenz associated with better outcomes in HIV-infected adults

Marked increase in the use of herbal medicines by Australians

Marked increase in the use of herbal medicines by Australians

Quark Pharmaceuticals' siRNAs examined alone and in xombination with chemotherapy

Quark Pharmaceuticals' siRNAs examined alone and in xombination with chemotherapy

Kamada reports positive data with inhaled Alpha-1 Antitrypsin in cystic fibrosis

Kamada reports positive data with inhaled Alpha-1 Antitrypsin in cystic fibrosis

FDA continues review of Takeda's NDA for Alogliptin

FDA continues review of Takeda's NDA for Alogliptin

FDA approves Rapaflo for treatment of symptoms due to benign prostatic hyperplasia

FDA approves Rapaflo for treatment of symptoms due to benign prostatic hyperplasia

Little use of biological alternatives to chemical pesticides

Little use of biological alternatives to chemical pesticides

Battling cancer at the single cell level

Battling cancer at the single cell level

New rapid test for rare leukemia

New rapid test for rare leukemia

Researchers explore issues related to multiple myeloma treatment

Researchers explore issues related to multiple myeloma treatment

Merck ditches taranabant for obesity

Merck ditches taranabant for obesity

Exelixis files investigational new drug application for anticancer compound

Exelixis files investigational new drug application for anticancer compound

Plethora Solutions completes European trial of PSD502 for premature ejaculation

Plethora Solutions completes European trial of PSD502 for premature ejaculation

Nanotubes detect tumors and deliver high-potency punch

Nanotubes detect tumors and deliver high-potency punch

Array BioPharma presents positive data on its glucokinase activators in type 2 diabetes

Array BioPharma presents positive data on its glucokinase activators in type 2 diabetes

Concert Pharmaceuticals initiates CTP-347 phase I clinical trial

Concert Pharmaceuticals initiates CTP-347 phase I clinical trial

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.